Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.

Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H.

J Bone Miner Res. 1999 Dec;14(12):2002-9.

2.

Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.

Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.

J Clin Endocrinol Metab. 1999 Sep;84(9):3174-81.

PMID:
10487683
3.

Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.

Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR.

J Pediatr Endocrinol Metab. 2001 May;14(5):525-8.

PMID:
11393573
4.

Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.

Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N, Tsuboi Y, Fukuda S, Honda K, Okada K, Ishikawa S, Saito T.

Clin Endocrinol (Oxf). 1997 Aug;47(2):215-21.

PMID:
9302397
5.

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.

Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.

J Bone Miner Res. 1994 May;9(5):631-7.

PMID:
8053391
6.

Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.

Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR.

J Pediatr Endocrinol Metab. 1998;11(3):413-9.

PMID:
11517957
7.

Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.

Thorsen K, Kristoffersson AO, Lorentzon RP.

Surgery. 1997 Nov;122(5):882-7.

PMID:
9369887
9.

Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.

Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.

Maturitas. 2004 Mar 15;47(3):185-93.

PMID:
15036488
10.
11.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
12.

Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.

Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J.

Clin Endocrinol (Oxf). 1998 May;48(5):561-8.

PMID:
9666867
13.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
15.

Is bone turnover a determinant of bone mass in rheumatoid arthritis?

Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.

J Rheumatol. 1998 Dec;25(12):2339-44.

PMID:
9858427
16.

Increased degradation of type I collagen in patients with inflammatory bowel disease.

Silvennoinen J, Risteli L, Karttunen T, Risteli J.

Gut. 1996 Feb;38(2):223-8.

17.

The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.

Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG.

Clin Endocrinol (Oxf). 1995 Mar;42(3):249-54.

PMID:
7758229
18.
20.

Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.

Scand J Gastroenterol. 2003 Mar;38(3):320-7.

PMID:
12737449

Supplemental Content

Support Center